HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Koren Selected Research

Dronedarone

1/2022Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation.
12/2020Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study.
3/2020Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
1/2020Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
1/2020Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
6/2015Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
3/2015A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
3/2014Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter.
2/2014Assessment of dronedarone utilization using US claims databases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Koren Research Topics

Disease

9Atrial Fibrillation
01/2022 - 03/2014
7Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2018
5Hypercholesterolemia
05/2018 - 06/2016
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2019 - 01/2018
3Atrial Flutter (Flutter, Atrial)
03/2020 - 03/2014
3Diabetes Mellitus
01/2020 - 10/2018
3Injection Site Reaction
01/2019 - 01/2018
3Heart Failure
03/2015 - 02/2014
1Tachycardia (Tachyarrhythmias)
01/2022
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2019
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2019
1Coronary Disease (Coronary Heart Disease)
05/2018
1Chronic Renal Insufficiency
01/2018
1Dyslipidemias (Dyslipidemia)
09/2016
1Hyperlipidemias (Hyperlipidemia)
09/2016
1Orthostatic Hypotension (Postural Hypotension)
03/2006
1Hypertension (High Blood Pressure)
03/2006

Drug/Important Bio-Agent (IBA)

9DronedaroneFDA Link
01/2022 - 02/2014
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 06/2016
6LipidsIBA
01/2020 - 01/2018
6alirocumabIBA
01/2019 - 01/2018
4Anti-Arrhythmia AgentsIBA
01/2022 - 03/2015
3oxidized low density lipoproteinIBA
05/2018 - 01/2018
2LDL CholesterolIBA
05/2018 - 01/2018
1Sotalol (Sotalol Hydrochloride)FDA LinkGeneric
01/2022
1CefiderocolIBA
01/2021
1Cephalosporins (Cephalosporin Antibiotics)IBA
01/2021
1SiderophoresIBA
01/2021
1CholesterolIBA
10/2019
1PCSK9 InhibitorsIBA
01/2018
1Proprotein Convertase 9IBA
01/2018
1evolocumabIBA
01/2018
1CreatinineIBA
02/2014
1Doxazosin (Cardura)FDA LinkGeneric
03/2006

Therapy/Procedure

10Therapeutics
01/2022 - 03/2006
2Catheter Ablation
01/2022 - 03/2020
2Electric Countershock (Cardioversion)
01/2020 - 01/2020